2V7C
| Crystal Structure of Rev-Erb beta | Descriptor: | ORPHAN NUCLEAR RECEPTOR NR1D2 | Authors: | Woo, E.-J, Jeong, D.G, Lim, M.-Y, Kim, S.J, Ryu, S.E. | Deposit date: | 2007-07-29 | Release date: | 2007-10-23 | Last modified: | 2011-07-13 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | Structural Insight Into the Constitutive Repression Function of the Nuclear Receptor Rev-Erbbeta J.Mol.Biol., 373, 2007
|
|
7XC0
| Crystal structure of Human RPTPH | Descriptor: | PHOSPHATE ION, Receptor-type tyrosine-protein phosphatase H | Authors: | Kim, M, Ryu, S.E. | Deposit date: | 2022-03-22 | Release date: | 2022-07-06 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (1.56 Å) | Cite: | Crystal structure of the catalytic domain of human RPTPH. Acta Crystallogr.,Sect.F, 78, 2022
|
|
7E73
| |
7E75
| |
4IKC
| Crystal Structure of catalytic domain of PTPRQ | Descriptor: | CHLORIDE ION, Phosphotidylinositol phosphatase PTPRQ, SULFATE ION | Authors: | Yu, K.R, Ryu, S.E, Kim, S.J. | Deposit date: | 2012-12-26 | Release date: | 2013-07-31 | Last modified: | 2023-11-08 | Method: | X-RAY DIFFRACTION (1.56 Å) | Cite: | Structural basis for the dephosphorylating activity of PTPRQ towards phosphatidylinositide substrates Acta Crystallogr.,Sect.D, 69, 2013
|
|
2ESB
| Crystal structure of human DUSP18 | Descriptor: | 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, ACETATE ION, Dual specificity protein phosphatase 18 | Authors: | Kim, S.J, Ryu, S.E, Jeong, D.G, Cho, Y.H, Yoon, T.S, Kim, J.H. | Deposit date: | 2005-10-25 | Release date: | 2006-06-06 | Last modified: | 2024-03-13 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Structure of human DSP18, a member of the dual-specificity protein tyrosine phosphatase family. Acta Crystallogr.,Sect.D, 62, 2006
|
|
2G6Z
| Crystal structure of human DUSP5 | Descriptor: | Dual specificity protein phosphatase 5, SULFATE ION | Authors: | Kim, S.J, Ryu, S.E. | Deposit date: | 2006-02-26 | Release date: | 2007-01-16 | Last modified: | 2011-07-13 | Method: | X-RAY DIFFRACTION (2.7 Å) | Cite: | Crystal structure of the catalytic domain of human DUSP5, a dual specificity MAP kinase protein phosphatase Proteins, 66, 2007
|
|
2GWO
| crystal structure of TMDP | Descriptor: | Dual specificity protein phosphatase 13 | Authors: | Kim, S.J, Ryu, S.E, Kim, J.H. | Deposit date: | 2006-05-05 | Release date: | 2007-03-20 | Last modified: | 2024-03-13 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | Crystal structure of human TMDP, a testis-specific dual specificity protein phosphatase: implications for substrate specificity Proteins, 66, 2007
|
|
1YZ4
| Crystal structure of DUSP15 | Descriptor: | SULFATE ION, dual specificity phosphatase-like 15 isoform a, octyl beta-D-glucopyranoside | Authors: | Kim, S.J, Ryu, S.E, Jeong, D.G, Yoon, T.S, Kim, J.H, Cho, Y.H, Jeong, S.K, Lee, J.W, Son, J.H. | Deposit date: | 2005-02-28 | Release date: | 2005-11-01 | Last modified: | 2021-11-10 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | Crystal structure of the catalytic domain of human VHY, a dual-specificity protein phosphatase Proteins, 61, 2005
|
|
1ZZW
| Crystal Structure of catalytic domain of Human MAP Kinase Phosphatase 5 | Descriptor: | 1,2-ETHANEDIOL, Dual specificity protein phosphatase 10, SULFATE ION | Authors: | Jeong, D.G, Yoon, T.S, Kim, J.H, Shim, M.Y, Jeong, S.K, Son, J.H, Ryu, S.E, Kim, S.J. | Deposit date: | 2005-06-14 | Release date: | 2006-07-04 | Last modified: | 2024-03-13 | Method: | X-RAY DIFFRACTION (1.6 Å) | Cite: | Crystal Structure of the Catalytic Domain of Human MAP Kinase Phosphatase 5: Structural Insight into Constitutively Active Phosphatase. J.Mol.Biol., 360, 2006
|
|
1IY7
| Crystal Structure of CPA and sulfamide-based inhibitor complex | Descriptor: | Carboxypeptidase A, PHENYLALANINE-N-SULFONAMIDE, ZINC ION | Authors: | Kim, S.J, Woo, J.R, Park, J.D, Kim, D.H, Ryu, S.E. | Deposit date: | 2002-07-24 | Release date: | 2003-01-28 | Last modified: | 2023-12-27 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Sulfamide-Based Inhibitors for Carboxypeptidase A. Novel Type Transition State Analogue Inhibitors for Zinc Proteases J.Med.Chem., 45, 2002
|
|
3HB1
| Crystal structure of ed-eya2 complexed with Alf3 | Descriptor: | ALUMINUM FLUORIDE, Eyes absent homolog 2 (Drosophila), MAGNESIUM ION | Authors: | Jung, S.K, Jeong, D.G, Ryu, S.E, Kim, S.J. | Deposit date: | 2009-05-03 | Release date: | 2009-12-01 | Last modified: | 2023-11-01 | Method: | X-RAY DIFFRACTION (2.51 Å) | Cite: | Crystal structure of ED-Eya2: insight into dual roles as a protein tyrosine phosphatase and a transcription factor Faseb J., 24, 2010
|
|
3HB0
| Structure of edeya2 complexed with bef3 | Descriptor: | BERYLLIUM TRIFLUORIDE ION, Eyes absent homolog 2 (Drosophila), MAGNESIUM ION | Authors: | Jung, S.K, Jeong, D.G, Ryu, S.E, Kim, S.J. | Deposit date: | 2009-05-03 | Release date: | 2009-12-01 | Last modified: | 2023-11-01 | Method: | X-RAY DIFFRACTION (2.5 Å) | Cite: | Crystal structure of ED-Eya2: insight into dual roles as a protein tyrosine phosphatase and a transcription factor Faseb J., 24, 2010
|
|
3LJ8
| Crystal Structure of MKP-4 | Descriptor: | Tyrosine-protein phosphatase | Authors: | Jeong, D.G, Yoon, T.S, Jung, S.-K, Park, H.S, Ryu, S.E, Kim, S.J. | Deposit date: | 2010-01-26 | Release date: | 2010-12-29 | Last modified: | 2023-11-01 | Method: | X-RAY DIFFRACTION (2.7 Å) | Cite: | Exploring binding sites other than the catalytic core in the crystal structure of the catalytic domain of MKP-4 Acta Crystallogr.,Sect.D, 67, 2011
|
|
5Y15
| Crystal structure of human DUSP28 | Descriptor: | Dual specificity phosphatase 28, PHOSPHATE ION | Authors: | Ku, B, Hong, W, Kim, S.J, Ryu, S.E. | Deposit date: | 2017-07-19 | Release date: | 2017-11-22 | Last modified: | 2023-11-22 | Method: | X-RAY DIFFRACTION (2.1 Å) | Cite: | Structural and biochemical analysis of atypically low dephosphorylating activity of human dual-specificity phosphatase 28 PLoS ONE, 12, 2017
|
|
5Y16
| Crystal structure of human DUSP28(Y102H) | Descriptor: | CHLORIDE ION, Dual specificity phosphatase 28, PHOSPHATE ION | Authors: | Ku, B, Kim, M, Kim, S.J, Ryu, S.E. | Deposit date: | 2017-07-19 | Release date: | 2017-11-22 | Last modified: | 2023-11-22 | Method: | X-RAY DIFFRACTION (2.399 Å) | Cite: | Structural and biochemical analysis of atypically low dephosphorylating activity of human dual-specificity phosphatase 28 PLoS ONE, 12, 2017
|
|
2NT2
| Crystal Structure of Slingshot phosphatase 2 | Descriptor: | Protein phosphatase Slingshot homolog 2, SULFATE ION | Authors: | Jung, S.K, Jeong, D.G, Yoon, T.S, Kim, J.H, Ryu, S.E, Kim, S.J. | Deposit date: | 2006-11-06 | Release date: | 2007-06-05 | Last modified: | 2023-08-30 | Method: | X-RAY DIFFRACTION (2.1 Å) | Cite: | Crystal structure of human slingshot phosphatase 2. Proteins, 68, 2007
|
|
5XJV
| Two intermediate states of conformation switch in dual specificity phosphatase 13a | Descriptor: | Dual specificity protein phosphatase 13 isoform A, PHOSPHATE ION | Authors: | Wei, C.H, Min, H.G, Chun, H.J, Ryu, S.E. | Deposit date: | 2017-05-04 | Release date: | 2018-04-11 | Last modified: | 2023-11-22 | Method: | X-RAY DIFFRACTION (1.69 Å) | Cite: | Two intermediate states of the conformational switch in dual specificity phosphatase 13a Pharmacol. Res., 128, 2018
|
|
1ATU
| UNCLEAVED ALPHA-1-ANTITRYPSIN | Descriptor: | ALPHA-1-ANTITRYPSIN | Authors: | Ryu, S.-E, Choi, H.-J. | Deposit date: | 1997-05-11 | Release date: | 1997-08-20 | Last modified: | 2023-08-02 | Method: | X-RAY DIFFRACTION (2.7 Å) | Cite: | The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved alpha1-antitrypsin at 2.7 A. Structure, 4, 1996
|
|
1PRX
| HORF6 A NOVEL HUMAN PEROXIDASE ENZYME | Descriptor: | HORF6 | Authors: | Choi, H.-J, Kang, S.W, Yang, C.-H, Rhee, S.G, Ryu, S.-E. | Deposit date: | 1998-04-03 | Release date: | 1998-06-17 | Last modified: | 2021-11-03 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Crystal structure of a novel human peroxidase enzyme at 2.0 A resolution. Nat.Struct.Biol., 5, 1998
|
|
1I7F
| CRYSTAL STRUCTURE OF THE HSP33 DOMAIN WITH CONSTITUTIVE CHAPERONE ACTIVITY | Descriptor: | GLYCEROL, HEAT SHOCK PROTEIN 33, SULFATE ION | Authors: | Kim, S.-J, Jeong, D.-G, Chi, S.-W, Lee, J.-S, Ryu, S.-E. | Deposit date: | 2001-03-09 | Release date: | 2001-05-09 | Last modified: | 2021-10-27 | Method: | X-RAY DIFFRACTION (2.7 Å) | Cite: | Crystal structure of proteolytic fragments of the redox-sensitive Hsp33 with constitutive chaperone activity Nat.Struct.Biol., 8, 2001
|
|
1IZ3
| Dimeric structure of FIH (Factor inhibiting HIF) | Descriptor: | FIH, SULFATE ION | Authors: | Lee, C, Kim, S.-J, Jeong, D.-G, Lee, S.M, Ryu, S.-E. | Deposit date: | 2002-09-19 | Release date: | 2003-06-10 | Last modified: | 2023-12-27 | Method: | X-RAY DIFFRACTION (2.8 Å) | Cite: | Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau. J.Biol.Chem., 278, 2003
|
|
1KU0
| Structure of the Bacillus stearothermophilus L1 lipase | Descriptor: | CALCIUM ION, L1 lipase, ZINC ION | Authors: | Jeong, S.-T, Kim, H.-K, Kim, S.-J, Chi, S.-W, Pan, J.-G, Oh, T.-K, Ryu, S.-E. | Deposit date: | 2002-01-18 | Release date: | 2002-08-21 | Last modified: | 2024-03-13 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Novel zinc-binding center and a temperature switch in the Bacillus stearothermophilus L1 lipase. J.Biol.Chem., 277, 2002
|
|
5X8M
| PD-L1 in complex with durvalumab | Descriptor: | Programmed cell death 1 ligand 1, durvalumab heavy chain, durvalumab light chain | Authors: | Heo, Y.S, Lee, H.T. | Deposit date: | 2017-03-03 | Release date: | 2017-08-16 | Method: | X-RAY DIFFRACTION (2.661 Å) | Cite: | Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab Sci Rep, 7, 2017
|
|
5X8L
| PD-L1 in complex with atezolizumab | Descriptor: | Programmed cell death 1 ligand 1, atezolizumab heavy chain, atezolizumab light chain | Authors: | Heo, Y.S, Lee, H.T. | Deposit date: | 2017-03-03 | Release date: | 2017-08-16 | Method: | X-RAY DIFFRACTION (3.1 Å) | Cite: | Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab Sci Rep, 7, 2017
|
|